Literature DB >> 2715819

Epidermal growth factor receptor in human glioma.

N Arita1, T Hayakawa, S Izumoto, T Taki, T Ohnishi, H Yamamoto, S Bitoh, H Mogami.   

Abstract

Distribution of the epidermal growth factor (EGF) receptor in the surgical specimen of the human glioma was studied by immunohistochemical techniques using a monoclonal anti-EGF receptor antibody. Of 11 gliomas examined, EGF receptors were detected in nine glioblastomas and in one fibrillary astrocytoma. In the majority of cells, staining was observed over the cell membrane. Nuclear and cytoplasmic staining was also seen. In four glioblastomas, EGF receptor-positive cells were diffusely distributed in the tumor tissue. In one glioblastoma and one fibrillary astrocytoma, only a few positive cells were observed. These results imply the possible role of EGF receptors in the cellular proliferation of the human glioma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715819     DOI: 10.3171/jns.1989.70.6.0916

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.

Authors:  K Strommer; M F Hamou; H Diggelmann; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 2.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 3.  Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors.

Authors:  D M Ashley; S K Batra; D D Bigner
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 4.  Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system.

Authors:  J G Chabot; S Kar; R Quirion
Journal:  Histochem J       Date:  1996-11

Review 5.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 6.  Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors.

Authors:  Vidyalakshmi Chandramohan; Duane A Mitchell; Laura A Johnson; John H Sampson; Darell D Bigner
Journal:  Future Oncol       Date:  2013-07       Impact factor: 3.404

7.  Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.

Authors:  Vidyalakshmi Chandramohan; Xuhui Bao; Stephen T Keir; Charles N Pegram; Scott E Szafranski; Hailan Piao; Carol J Wikstrand; Roger E McLendon; Chien-Tsun Kuan; Ira H Pastan; Darell D Bigner
Journal:  Clin Cancer Res       Date:  2013-07-15       Impact factor: 12.531

8.  Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

Authors:  E M Hiesiger; R L Hayes; D M Pierz; G N Budzilovich
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

9.  p53 protein and epidermal growth factor receptor expression in human astrocytomas.

Authors:  R Kordek; W Biernat; J Alwasiak; R Maculewicz; R Yanagihara; P P Liberski
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

10.  DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors.

Authors:  T Arai; K Ichimura; K Hirakawa; Y Yuasa
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.